Application of Metabolomics for Translational and Biological Research (R01)

The summary for the Application of Metabolomics for Translational and Biological Research (R01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Application of Metabolomics for Translational and Biological Research (R01): -Purpose. Metabolomics enables simultaneous identification and analysis of multiple metabolites in cells, tissues and body fluids. This Funding Opportunity Announcement (FOA) is an initiative sponsored by several NIH institutes to promote the application of metabolomic technologies for translational research in human health and disease to enable/improve disease detection, diagnosis, risk assessment, prognosis, and prediction of therapeutic responses. -Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award mechanism and runs in parallel with an FOA of identical scientific scope, PA-07-302 that solicits applications under the R21 mechanism for pilot/exploratory projects. -Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.

Federal Grant Title:	Application of Metabolomics for Translational and Biological Research (R01)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Education Food and Nutrition Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PA-07-301
Type of Funding:	Grant
CFDA Numbers:	93.121
CFDA Descriptions:	Oral Diseases and Disorders Research
Current Application Deadline:	Multiple Receipt Dates - See Link to Full Announce
Original Application Deadline:	Multiple Receipt Dates - See Link to Full Announce
Posted Date:	Jan 17, 2007
Creation Date:	Dec 05, 2008
Archive Date:	Feb 02, 2010
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Public and State controlled institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Foreign institutions are eligible to apply.
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants: • Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed...; • NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00 Clinical Trial ...; • Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional); • Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research ...; • Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Scie...; • Epidemiological and Behavioral Research in Oral Health; • Metagenomic Analyses of the Oral Microbiome; • Phase Iii Clinical Trials in Oral Infectious Diseases
More Grants from the National Institutes of Health: • Resource-Related Research Projects for Development of Models and Related Materials for Stu...; • Animal and Biological Material Resource Centers (P40 Clinical Trial Not Allowed); • Informatics, Coordination and Service Center for the Mutant Mouse Resource and Research Ce...; • Diabetes Research Centers (P30 Clinical Trial Optional); • Limited Competition Renewal for the Continuation of the Liver Cirrhosis Network: Clinical ...